{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:23:05Z","timestamp":1789716185687,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3987,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1111\/j.0022-202x.2004.23538.x","type":"journal-article","created":{"date-parts":[[2005,1,17]],"date-time":"2005-01-17T11:45:29Z","timestamp":1105962329000},"page":"144-150","source":"Crossref","is-referenced-by-count":40,"title":["Peripheral CD8+ T Cell Tolerance Against Melanocytic Self-Antigens in the Skin Is Regulated in Two Steps by CD4+ T Cells and Local Inflammation: Implications for the Pathophysiology of Vitiligo"],"prefix":"10.1016","volume":"124","author":[{"given":"Julia","family":"Steitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"B\u00fcchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"T\u00fcting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0010","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.282.5392.1338","article-title":"Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking","volume":"282","author":"Alferink","year":"1998","journal-title":"Science"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2249.1996.d01-727.x","article-title":"Tyrosinase as an autoantigen in patients with vitiligo","volume":"105","author":"Baharav","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s002620050280","article-title":"Melanoma and vitiligo: Immunology's Grecian urn","volume":"42","author":"Berd","year":"1996","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1084\/jem.185.3.453","article-title":"Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma","volume":"185","author":"Bloom","year":"1997","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0030","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1084\/jem.190.11.1717","article-title":"Coupling and uncoupling of tumor immunity and autoimmunity","volume":"190","author":"Bowne","year":"1999","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0035","first-page":"253","article-title":"Genetic vaccination with \u201cself\u201d tyrosinase-related protein 2 causes melanoma eradication but not vitiligo","volume":"60","author":"Bronte","year":"2000","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0040","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.4049\/jimmunol.158.7.3270","article-title":"Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL","volume":"158","author":"Brossart","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0045","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1084\/jem.191.7.1221","article-title":"Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy","volume":"3","author":"Colella","year":"2000","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0050","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.1995.01690150078015","article-title":"Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells","volume":"131","author":"Cui","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0055","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1210\/jc.2002-021845","article-title":"Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up","volume":"88","author":"Dittmar","year":"2003","journal-title":"Clin Endocrinol Metab"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0060","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO;2-E","article-title":"Autoantibodies to tyrosinase: The bridge between melanoma and vitiligo","volume":"79","author":"Fishman","year":"1997","journal-title":"Cancer"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0070","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/JVI.71.3.1842-1849.1997","article-title":"Construction of adenovirus vectors through Cre-lox recombination","volume":"71","author":"Hardy","year":"1997","journal-title":"J Virol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0075","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0085","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1158\/0008-5472.CAN-03-3227","article-title":"Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin","volume":"64","author":"Lane","year":"2004","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0090","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0095","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1046\/j.0022-202x.2001.01605.x","article-title":"Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo","volume":"117","author":"Le Gal","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0100","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2395::AID-IMMU2395>3.0.CO;2-D","article-title":"Failure to induce organ-specific autoimmunity by breaking of tolerance: Importance of the microenvironment","volume":"28","author":"Limmer","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.184.2.647","article-title":"Identification of epitope mimics recognized by CTL reactive to the melanoma\/melanocyte-derived peptide MART-1(27\u201335)","volume":"184","author":"Loftus","year":"1996","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0110","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1523-1747.2003.12413.x","article-title":"Cytotoxic T lymphocyte reactivity to gp100, MelanA\/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients","volume":"121","author":"Mandelcorn-Monson","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0115","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0120","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0125","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells","volume":"198","author":"Overwijk","year":"2003","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0130","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","article-title":"Vaccination with a recombinant vaccinia virus encoding a \u201cself\u201d antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes","volume":"96","author":"Overwijk","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0135","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: The role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-5699(97)84664-6","article-title":"Cancer vaccines based on the identification of genes encoding cancer regression antigens","volume":"18","author":"Rosenberg","year":"1997","journal-title":"Immunol Today"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","article-title":"Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy","volume":"19","author":"Rosenberg","year":"1996","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0150","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0959-8049(94)90493-6","article-title":"Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients","volume":"30","author":"Scheibenbogen","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0155","first-page":"6995","article-title":"Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model","volume":"60","author":"Schreurs","year":"2000","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0160","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.gt.3301634","article-title":"Genetic immunization with a melanocytic self-antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity","volume":"9","author":"Steitz","year":"2002","journal-title":"Gene Ther"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0170","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.gt.3301521","article-title":"Adenovirus-transduced DC stimulate cellular immunity to melanoma via a CD4+ T cell-dependent mechanism","volume":"8","author":"Steitz","year":"2001","journal-title":"Gene Ther"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I","article-title":"Genetic immunization with human tyrosinase-related protein 2: Implications for the immunotherapy of melanoma","volume":"86","author":"Steitz","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.0022-202x.2001.01631.x","article-title":"A close-up view of migrating Langerhans cells in the skin","volume":"118","author":"Stoitzner","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23538.x_bb0185","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of t cell-mediated vitiligo","volume":"192","author":"Yee","year":"2000","journal-title":"J Exp Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15320960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15320960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T16:41:32Z","timestamp":1682959292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15320960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0022202X15320960"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2004.23538.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}